Skip to main content
Premium Trial:

Request an Annual Quote

SynapDx Licenses Gene Expression Technology from Children's Hospital Boston

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Startup SynapDx said today it has licensed technology from Children's Hospital Boston for the development of blood-based tests for the early detection of autism spectrum disorders.

Citing statistics from the Centers for Disease Control, SynapDx said about one in every 110 children in the US has the disorder.

In an e-mail, Theresa Tribble, senior director of Clinical Market Development for the Southborough, Mass.-based firm told GenomeWeb Daily News that it has licensed a test method from the hospital, "specifically one that uses gene expression to distinguish autism cases."

SynapDx's initial focus with the technology will be to develop an assay "targeted at specialists who evaluate children with possible developmental concerns to more effectively differentiate children with autism spectrum disorders from those with other types of developmental disorders," she added.

SynapDx said that the technology being licensed was developed in collaboration with Louis Kunkel and Isaac Kohane at Children's Hospital. Kunkel is the director of the Children's Genomic Program. Kohane is the director of the informatics program at the hospital.

Financial terms of the deal were not disclosed

According to SynapDx's website, its approach measures RNA gene expression differences, and the firm is in the process of validating its methods. The company was founded about a year ago by Stanley Lapidus, who earlier had founded Helicos BioSciences, Cytyc, and Exact Sciences.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.